April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Quantitative Stability Assessment Of Glaucoma-causing And Single Nucleotide Polymorphism Variants Of The Olfactomedin Domain Of Myocilin
Author Affiliations & Notes
  • Raquel L. Lieberman
    School of Chemistry & Biochemistry, Georgia Institute of Technology, Atlanta, Georgia
  • J. N. Burns
    School of Chemistry & Biochemistry, Georgia Institute of Technology, Atlanta, Georgia
  • Susan D. Orwig
    School of Chemistry & Biochemistry, Georgia Institute of Technology, Atlanta, Georgia
  • Chandler A. Walker
    School of Chemistry & Biochemistry, Georgia Institute of Technology, Atlanta, Georgia
  • Katherine C. Turnage
    School of Chemistry & Biochemistry, Georgia Institute of Technology, Atlanta, Georgia
  • Footnotes
    Commercial Relationships  Raquel L. Lieberman, None; J. N. Burns, None; Susan D. Orwig, None; Chandler A. Walker, None; Katherine C. Turnage, None
  • Footnotes
    Support  Glaucoma Research Foundation, American Health Assistance Foundation, Pew Foundation
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2427. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Raquel L. Lieberman, J. N. Burns, Susan D. Orwig, Chandler A. Walker, Katherine C. Turnage; Quantitative Stability Assessment Of Glaucoma-causing And Single Nucleotide Polymorphism Variants Of The Olfactomedin Domain Of Myocilin. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2427.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Myocilin variants, localized to the olfactomedin (OLF) domain, are linked to early onset glaucoma. Disease-causing myocilin variants accumulate in the endoplasmic reticulum (ER) of trabecular meshwork cells instead of being secreted to the extracellular matrix involved in regulating aqueous humor flow. Cell secretion studies at variable temperature support the hypothesis that myocilin glaucoma pathogenesis originates from a trafficking defect in which compromised biophysical properties of myocilin variants are detected by the ER quality control network, and inefficient clearing leads to aggregates that are toxic to TM cells. To directly evaluate the biophysical stability of disease-causing variants, we compared the melting temperature of nineteen purified OLF variants.

Methods: : The OLF domain of myocilin was expressed recombinantly and purified to homogeneity. The stability was measured with a facile fluorescence thermal stability assay developed in the lab. The stability was measured with and without trimethylamine-N-oxide, which was previously shown to stabilize OLF. For the stable variants, circular dichroism spectra were obtained to identify structural changes compared to wild-type OLF. All data were compared in reference to previously published solubility and secretion data by other groups, as well as age of glaucoma diagnosis.

Results: : Variants with lower melting temperatures are correlated with more severe glaucoma phenotypes, and the trimethylamine-N-oxide is capable of restoring stability of all but the least stable variants to wild-type levels. Interestingly, three reported disease lesions, A427T, G246R, and A445V, exhibited both stability and circular dichroism spectra comparable to those of wild-type OLF, suggesting that these are ambiguous variants. Similarly, three annotated single nucleotide polymorphism variants K398R, E396D and E352Q, are also indistinguishable from wild-type OLF and are likely benign variants.

Conclusions: : Our work provides the first quantitative demonstration of compromised stability among many identified OLF mutants to strengthen the proposed disease mechanisms for myocilin glaucoma. Stability assessment could represent a more general approach to the evaluation of different missense mutant proteins implicated in other genetic disorders.

Keywords: protein purification and characterization • protein structure/function • proteins encoded by disease genes 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×